Regulus Therapeutics

Last updated: April 15, 2024

Joseph Hagan - CEO
Joseph Hagan - CEO
Country: USA | Funding: $480.9M (+)

Website: http://regulusrx.com

Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.